Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Officer, Director, 10%+ Owner
-
Stock Symbol
-
LIPO on Nasdaq
Jonathan H. Kaufman - trading volume in the past year for Lipella Pharmaceuticals Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
899K |
$682K |
$0.76 |
May 14, 2024 |
Direct |
|
|
Series C Voting Convertible Preferred Stock |
303K |
|
|
Dec 31, 2024 |
By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) |
Common Stock |
|
Stock Options |
80K |
|
|
Mar 15, 2024 |
Direct |
Common Stock |
|
Common Stock Purchase Warrants |
11.8K |
|
|
Dec 31, 2024 |
By Self as proxy and power of attorney for Spartan |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.